Kit for detection of microorganism
Abstract
A kit for use in a method for detecting live cells, injured cells and dead cells of a microorganism in a test sample by a nucleic acid amplification method is disclosed. The kit includes a cross-linker capable of cross-linking DNA by irradiation with light having a wavelength of 350 nm to 700 nm, medium, and a primer (s) for amplifying a DNA target region in the microorganism by a nucleic acid amplification method. The nucleic acid amplification method may be a PCR, LAMP, SDA, LCR or DNA microarray method. A cross-linker may be included in the kit such as ethidium monoazide, ethidium diazide, psoralen, 4,5′,8-trimethyl psoralen, or 8-methoxy psoralen.
Claims
exact text as granted — not AI-modified1 . A kit for use in a method for detecting live cells, injured cells and dead cells of a microorganism in a test sample by a nucleic acid amplification method, which comprises the following components:
a cross-linker capable of cross-linking DNA by irradiation with light having a wavelength of 350 nm to 700 nm; a medium; and a primer(s) for amplifying a target region of a DNA of a microorganism, which is a detection target, by the nucleic acid amplification method.
2 . The kit according to claim 1 , wherein the method comprises the following steps:
a) adding the cross-linker capable of cross-linking DNA by irradiation with light having a wavelength of 350 nm to 700 nm to the test sample; b) irradiating the test sample to which the cross-linker is added with light having a wavelength of 350 nm to 700 nm; c) removing the cross-linker contained in the test sample irradiated with light; d) adding a medium to the test sample from which the cross-linker is removed and incubating the test sample; e) adding again the cross-linker capable of cross-linking a DNA by irradiation with light having a wavelength of 350 nm to 700 nm to the incubated test sample; f) irradiating the test sample to which the cross-linker is added with light having a wave length of 350 nm to 700 nm; g) extracting a DNA from the test sample and amplifying a target region of the extracted DNA by a nucleic acid amplification method; and h) analyzing the amplified product.
3 . The kit according to claim 1 , wherein the nucleic acid amplification method is a PCR, LAMP, SDA, LCR or DNA microarray method.
4 . The kit according to claim 1 , wherein the cross-linker is selected from the group consisting of ethidium monoazide, ethidium diazide, psoralen, 4,5′,8-trimethyl psoralen, and 8-methoxy psoralen.
5 . The kit according to claim 2 , wherein the nucleic acid amplification method is a PCR, LAMP, SDA, LCR or DNA microarray method.
6 . The kit according to claim 2 , wherein the cross-linker is selected from the group consisting of ethidium monoazide, ethidium diazide, psoralen, 4,5′,8-trimethyl psoralen, and 8-methoxy psoralen.
7 . The kit according to claim 3 , wherein the cross-linker is selected from the group consisting of ethidium monoazide, ethidium diazide, psoralen, 4,5′,8-trimethyl psoralen, and 8-methoxy psoralen.
8 . The kit according to claim 5 , wherein the cross-linker is selected from the group consisting of ethidium monoazide, ethidium diazide, psoralen, 4,5′,8-trimethyl psoralen, and 8-methoxy psoralen.Join the waitlist — get patent alerts
Track US2012277121A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.